Search

Mark L. Berch

Examiner (ID: 99)

Most Active Art Unit
1202
Art Unit(s)
1202, 1624, 1622, 1802, 2899, 1614, 1611
Total Applications
3573
Issued Applications
2301
Pending Applications
170
Abandoned Applications
1103

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4555187 [patent_doc_number] => 07820815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthines' [patent_app_type] => utility [patent_app_number] => 11/267235 [patent_app_country] => US [patent_app_date] => 2005-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3885 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820815.pdf [firstpage_image] =>[orig_patent_app_number] => 11267235 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/267235
Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthines Nov 3, 2005 Issued
Array ( [id] => 5591464 [patent_doc_number] => 20060040916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Carbapenem compound crystals and injection preparations' [patent_app_type] => utility [patent_app_number] => 11/259509 [patent_app_country] => US [patent_app_date] => 2005-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11762 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040916.pdf [firstpage_image] =>[orig_patent_app_number] => 11259509 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/259509
Carbapenem compound crystals and injection preparations Oct 25, 2005 Abandoned
Array ( [id] => 5297361 [patent_doc_number] => 20090012287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Process for Producing Penam Compound' [patent_app_type] => utility [patent_app_number] => 11/665006 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2269 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012287.pdf [firstpage_image] =>[orig_patent_app_number] => 11665006 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/665006
Process for producing penam compound useful for preparing tazobactam Oct 24, 2005 Issued
Array ( [id] => 4688988 [patent_doc_number] => 20080033169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'Crystalline Form Of Cefdinir Ammonium Salt As An Intermediate For The Preparation Of Pure Cefdinir' [patent_app_type] => utility [patent_app_number] => 11/719599 [patent_app_country] => US [patent_app_date] => 2005-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2516 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20080033169.pdf [firstpage_image] =>[orig_patent_app_number] => 11719599 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/719599
Crystalline Form Of Cefdinir Ammonium Salt As An Intermediate For The Preparation Of Pure Cefdinir Oct 23, 2005 Abandoned
Array ( [id] => 5591680 [patent_doc_number] => 20060041132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Novel triazolo pyrimidine compounds' [patent_app_type] => utility [patent_app_number] => 11/255838 [patent_app_country] => US [patent_app_date] => 2005-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6113 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20060041132.pdf [firstpage_image] =>[orig_patent_app_number] => 11255838 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/255838
Novel triazolo pyrimidine compounds Oct 23, 2005 Abandoned
Array ( [id] => 8146750 [patent_doc_number] => 08163754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Purine derivatives for use as adenosine A-2A receptor agonists' [patent_app_type] => utility [patent_app_number] => 11/576607 [patent_app_country] => US [patent_app_date] => 2005-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32352 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163754.pdf [firstpage_image] =>[orig_patent_app_number] => 11576607 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/576607
Purine derivatives for use as adenosine A-2A receptor agonists Oct 20, 2005 Issued
Array ( [id] => 4916496 [patent_doc_number] => 20080097097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Process for Preparing Purine Compounds' [patent_app_type] => utility [patent_app_number] => 11/662536 [patent_app_country] => US [patent_app_date] => 2005-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5137 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20080097097.pdf [firstpage_image] =>[orig_patent_app_number] => 11662536 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/662536
Process for Preparing Purine Compounds Oct 9, 2005 Abandoned
Array ( [id] => 5160474 [patent_doc_number] => 20070173518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'CRISTALLINE AND AMORPHOUS FORM OF A TRIAZOLO (4,5-D) PYRIDIMINE COMPOUND' [patent_app_type] => utility [patent_app_number] => 11/240801 [patent_app_country] => US [patent_app_date] => 2005-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7651 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20070173518.pdf [firstpage_image] =>[orig_patent_app_number] => 11240801 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/240801
Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound Oct 2, 2005 Issued
Array ( [id] => 892579 [patent_doc_number] => 07345169 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-18 [patent_title] => 'Process for the preparation of cephalosporin antibiotic' [patent_app_type] => utility [patent_app_number] => 11/240382 [patent_app_country] => US [patent_app_date] => 2005-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4061 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/345/07345169.pdf [firstpage_image] =>[orig_patent_app_number] => 11240382 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/240382
Process for the preparation of cephalosporin antibiotic Oct 2, 2005 Issued
Array ( [id] => 5678404 [patent_doc_number] => 20060183760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'New purine derivatives' [patent_app_type] => utility [patent_app_number] => 11/238533 [patent_app_country] => US [patent_app_date] => 2005-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23405 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183760.pdf [firstpage_image] =>[orig_patent_app_number] => 11238533 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/238533
Purine derivatives Sep 27, 2005 Issued
Array ( [id] => 566508 [patent_doc_number] => 07465720 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-16 [patent_title] => 'Proteasome inhibiting β-lactam compounds' [patent_app_type] => utility [patent_app_number] => 11/224589 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 9466 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/465/07465720.pdf [firstpage_image] =>[orig_patent_app_number] => 11224589 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/224589
Proteasome inhibiting β-lactam compounds Sep 11, 2005 Issued
Array ( [id] => 5739251 [patent_doc_number] => 20060009642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Methods for the synthesis of substituted purines' [patent_app_type] => utility [patent_app_number] => 11/223429 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15805 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009642.pdf [firstpage_image] =>[orig_patent_app_number] => 11223429 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/223429
Methods for the synthesis of substituted purines Sep 8, 2005 Abandoned
Array ( [id] => 5866293 [patent_doc_number] => 20060100424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Process for producing Cefepime and cephalosporin analogues' [patent_app_type] => utility [patent_app_number] => 11/221751 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1559 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100424.pdf [firstpage_image] =>[orig_patent_app_number] => 11221751 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/221751
Process for producing Cefepime and cephalosporin analogues Sep 8, 2005 Issued
Array ( [id] => 5057677 [patent_doc_number] => 20070060599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Crystalline forms of [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one' [patent_app_type] => utility [patent_app_number] => 11/222597 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6436 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060599.pdf [firstpage_image] =>[orig_patent_app_number] => 11222597 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/222597
Crystalline forms of [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one Sep 8, 2005 Abandoned
Array ( [id] => 5656525 [patent_doc_number] => 20060142261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Crystalline anhydrous cefdinir and crystalline cefdinir hydrates' [patent_app_type] => utility [patent_app_number] => 11/222313 [patent_app_country] => US [patent_app_date] => 2005-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18556 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142261.pdf [firstpage_image] =>[orig_patent_app_number] => 11222313 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/222313
Crystalline anhydrous cefdinir and crystalline cefdinir hydrates Sep 7, 2005 Abandoned
Array ( [id] => 5656827 [patent_doc_number] => 20060142563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Crystalline anhydrous cefdinir and crystalline cefdinir hydrates' [patent_app_type] => utility [patent_app_number] => 11/222299 [patent_app_country] => US [patent_app_date] => 2005-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18552 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 65 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142563.pdf [firstpage_image] =>[orig_patent_app_number] => 11222299 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/222299
Crystalline anhydrous cefdinir and crystalline cefdinir hydrates Sep 7, 2005 Abandoned
Array ( [id] => 5760731 [patent_doc_number] => 20060211676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Crystalline anhydrous cefdinir and crystalline cefdinir hydrates' [patent_app_type] => utility [patent_app_number] => 11/221427 [patent_app_country] => US [patent_app_date] => 2005-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18555 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 49 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211676.pdf [firstpage_image] =>[orig_patent_app_number] => 11221427 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/221427
Crystalline anhydrous cefdinir and crystalline cefdinir hydrates Sep 7, 2005 Abandoned
Array ( [id] => 5814990 [patent_doc_number] => 20060084668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Isolated valacyclovir impurity, process for the preparation of valacyclovir impurity and use as a reference standard' [patent_app_type] => utility [patent_app_number] => 11/221124 [patent_app_country] => US [patent_app_date] => 2005-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4396 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084668.pdf [firstpage_image] =>[orig_patent_app_number] => 11221124 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/221124
Isolated valacyclovir impurity, process for the preparation of valacyclovir impurity and use as a reference standard Sep 5, 2005 Issued
Array ( [id] => 5739117 [patent_doc_number] => 20060009508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Compounds for the preparation of carbapenem-type antibacterial agents' [patent_app_type] => utility [patent_app_number] => 11/219394 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10659 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009508.pdf [firstpage_image] =>[orig_patent_app_number] => 11219394 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/219394
Compounds for the preparation of carbapenem-type antibacterial agents Sep 1, 2005 Issued
Array ( [id] => 4867476 [patent_doc_number] => 20080146535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Compositions comprising carbacephem beta-lactam antibiotics and beta-lactamase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/218841 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9490 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146535.pdf [firstpage_image] =>[orig_patent_app_number] => 11218841 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/218841
Compositions comprising carbacephem beta-lactam antibiotics and beta-lactamase inhibitors Sep 1, 2005 Abandoned
Menu